-
Recent Posts
Categories
- Adventure (3)
- Art (5)
- Crafts (1)
- Culture (8)
- FDA (2)
- Health policy (10)
- JAMA (1)
- Legal (3)
- Medicine (12)
- Medscape (7)
- Music (1)
- New York Times (4)
- Science (7)
- Science magazine (1)
- Smithsonian.com (7)
- The Lancet (1)
- The New Scientist (1)
- The Washington Post (3)
- Travel (2)
- Wall Street Journal (1)
Social Media
Archives
Contact
Category Archives: FDA
‘Nonsensical’ Limits on Supportive Drugs Complicate Cancer Care
November 13, 2024 A young woman with breast cancer was experiencing such intense hot flashes from her triplet chemotherapy regimen, AC-T, that she begged to stop treatment. Her oncologist, Ramy Sedhom, MD, suggested she take oxybutynin, an inexpensive drug for overactive … Continue reading
Posted in FDA, Medicine, Medscape
Tagged anti-nausea, cancer, cancer care, ethics, FDA, health insurance, medical ethics, odanesetron, oncology, pill limits, prior authorization
Leave a comment
Should the FDA Reconsider Antidepressant Boxed Warnings?
December 23, 2024 For almost two decades, antidepressants have carried boxed warnings linking the medications to an increased risk for suicidal thoughts and behaviors in young people. Paradoxically, and for almost as long, evidence suggests these warnings may have led … Continue reading
Posted in FDA, Health policy, Medicine, Medscape
Tagged adolescents, antidepressants, FDA, Medscape Medical News, mental health, psychiatry, psychology, suicide
Leave a comment